EMVEUA 📈 UBS(Lux)Fund Solutions – - Overview
Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: LU0446734369 • Eurozone Large-Cap Equity
EMVEUA: Investment, Stocks, Bonds, ETFs, Funds
‣ Company URL: http://www.credit-suisse.com ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Dev Ezn TME NR EUR
Additional Sources for EMVEUA ETF
EMVEUA ETF Overview
| Market Cap in USD | 138m |
| Category | Eurozone Large-Cap Equity |
| TER | 0.25% |
| IPO / Inception | 2009-10-02 |
EMVEUA ETF Ratings
| Growth 5y | 56.3% |
| Fundamental | - |
| Dividend | 65.2% |
| Rel. Strength Industry | 78.5 |
| Analysts | - |
| Fair Price Momentum | 43.68 EUR |
| Fair Price DCF | - |
EMVEUA Dividends
| Dividend Yield 12m | 3.52% |
| Yield on Cost 5y | 4.80% |
| Annual Growth 5y | 13.32% |
| Payout Consistency | 92.2% |
EMVEUA Growth Ratios
| Growth Correlation 3m | -66.3% |
| Growth Correlation 12m | 74.9% |
| Growth Correlation 5y | 89.8% |
| CAGR 5y | 6.34% |
| CAGR/Mean DD 5y | 0.86 |
| Sharpe Ratio 12m | 0.39 |
| Alpha | -11.14 |
| Beta | 0.64 |
| Volatility | 13.61% |
| Current Volume | 0.9k |
| Average Volume 20d | 37.8k |
What is the price of EMVEUA stocks?
As of January 05, 2025, the stock is trading at EUR 43.88 with a total of 922 shares traded.
Over the past week, the price has changed by +0.01%, over one month by -0.58%, over three months by -1.58% and over the past year by +9.15%.
As of January 05, 2025, the stock is trading at EUR 43.88 with a total of 922 shares traded.
Over the past week, the price has changed by +0.01%, over one month by -0.58%, over three months by -1.58% and over the past year by +9.15%.
Is UBS(Lux)Fund Solutions – a good stock to buy?
Partly, yes. Based on ValueRay Analyses, UBS(Lux)Fund Solutions – (SW:EMVEUA) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.32 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMVEUA as of January 2025 is 43.68. This means that EMVEUA is currently overvalued and has a potential downside of -0.46%.
Partly, yes. Based on ValueRay Analyses, UBS(Lux)Fund Solutions – (SW:EMVEUA) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.32 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMVEUA as of January 2025 is 43.68. This means that EMVEUA is currently overvalued and has a potential downside of -0.46%.
Is EMVEUA a buy, sell or hold?
UBS(Lux)Fund Solutions – has no consensus analysts rating.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
What are the forecast for EMVEUA stock price target?
According to ValueRays Forecast Model, EMVEUA UBS(Lux)Fund Solutions – will be worth about 48 in January 2026. The stock is currently trading at 43.88. This means that the stock has a potential upside of +9.46%.
According to ValueRays Forecast Model, EMVEUA UBS(Lux)Fund Solutions – will be worth about 48 in January 2026. The stock is currently trading at 43.88. This means that the stock has a potential upside of +9.46%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48 | 9.5% |